<DOC>
	<DOCNO>NCT02682485</DOCNO>
	<brief_summary>Rationale : The surgical complication intestinal anastomotic leak remain clear present danger patient despite advance surgical technique ever powerful antibiotic . No surgeon immune complication leak rate change decade . The consequence leak ( peritonitis , sepsis , death ) severe case rectal cancer , divert ileostomy routinely perform divert fecal stream away heal anastomosis . We recently discover certain intestinal bacteria , capacity express collagenase cleave MMP9 ( Matrix metallopeptidase 9 ) active collagen degrade form , play key causative role anastomotic leak . These bacteria often escape elimination due failure current antibiotic regimen delivery method remain functionally durable anastomotic tissue site . Purpose : This phase II clinical trial track , real time , process anastomotic healing associate microbiome perform serial endoscopic surveillance ( SES ) follow rectal cancer resection . By capture anastomotic image associate microbial inflammatory mediator anastomotic fluid via SES perform three time point follow rectal cancer resection , correlate heal microbial composition inflammatory mediator status . Patients randomize , time point , receive lavage anastomosis either saline triple antibiotic solution ( ciprofloxacin , metronidazole , neomycin ) . An anastomotic healing score capture SES compare two treatment arm correlate microbial inflammatory mediator analyse fluid sample determine intestinal microbe influence process anastomotic healing .</brief_summary>
	<brief_title>Serial Endoscopic Surveillance &amp; Direct Topical Antibiotics Define Role Microbes Anastomotic Healing</brief_title>
	<detailed_description>OBJECTIVES - Perform repeat postoperative endoscopy anastomotic tissue sit patient undergo low anterior resection rectal cancer divert ileostomy . - Demonstrate SES reliably discriminate anastomosis progress along continuum toward normal heal versus heal pathologically image evaluated jury blind treatment . - Demonstrate anastomosis judge progress pathologically harbor distinct microbial specie predictive inflammatory mediator . - Demonstrate anastomotic tissue lavaged antibiotic directly via endoscopy ( ciprofloxacin , metronidazole , neomycin ) , microbial pathogen escape conventional antibiotic eliminate anastomotic healing progress normally . - Determine anastomotic healing score , microbial analysis , and/or inflammatory mediator analyse identify predict symptomatic clinically relevant anastomotic complication . STUDY This randomize , multicenter study . All patient undergo resection rectal cancer low anterior resection anastomosis within 10cm anal verge divert ileostomy . Patients undergo three endoscopy : one intra-operative endoscopy ( POD0 ) two post-operative endoscopy ( POD3-7 , POD12-28 ) ( POD = post-operative day ) . During SES procedure , anastomosis lavaged saline , fluid collect suction , image take anastomosis lavaged either saline antibiotic solution compose metronidazole , ciprofloxacin neomycin . Patients ' clinical course follow chart review 6 7 month follow surgery . PROJECTED ACCRUAL A total 200 patient ( approximately 100 per treatment arm ) accrue study within 4 year .</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Anastomotic Leak</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<mesh_term>Neomycin</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>Inclusion Criteria Diagnosis rectal cancer Scheduled undergo low anterior resection ( plan anastomosis within 10cm anal verge ) divert ileostomy 18 year age older Able provide inform consent Exclusion Criteria Prior medical history suspect diagnosis inflammatory bowel disease irritable bowel syndrome Pregnant breastfeeding Allergy lidocaine , ciprofloxacin , metronidazole neomycin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Rectal Cancer</keyword>
	<keyword>low anterior resection</keyword>
	<keyword>SES</keyword>
	<keyword>SES-DTA</keyword>
	<keyword>anastomotic leak</keyword>
	<keyword>anastomotic healing</keyword>
	<keyword>intestinal healing</keyword>
	<keyword>anastomosis</keyword>
</DOC>